A new clinical trial involving more than 300 people has shown that Lucentis, the injectable drug, not only treats macular edema, but also is as effective as laser surgery for proliferative diabetic retinopathy. Treatment for both diseases also can often restore vision.
MLERFi began funding the research that ultimately led to this breakthrough more than 10 years ago. More #InspiredResearch. You can read about it here.